Beryl Drugs Ltd share price logo

Beryl Drugs Ltd Share Price (524606)

Check the latest share price of Beryl Drugs Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹20.094.96%

as on 04:01PM, 13 Jun 2025

BSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Beryl Drugs Ltd Stock Performance

Get live Beryl Drugs Ltd share price, day's high and low, historical returns, and market stats.

  • Day's Low

    ₹18.2
    Day's Price Range
    ₹20.09
  • 52 Week's Low

    52 Week's High

    ₹17.35
    52-Week Price Range
    ₹46
1 Month Return+ 2.2 %
3 Month Return-16.19 %
1 Year Return-44.94 %
3 Year Return+ 116.23 %
5 Year Return+ 249.3 %
Previous Close₹19.14
Open₹18.20
Volume19.30K
Upper Circuit₹20.09
Lower Circuit₹18.19

Beryl Drugs Ltd Fundamentals & Key Indicators

Check Beryl Drugs Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹10.13 Cr

Return on Equity (ROE)

9.07

PE Ratio (TTM)

0

Return on capital employed (ROCE)

11.38

Beta (LTM)

0.45

P/B Ratio

1.67

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

-142.86

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

How to invest in Beryl Drugs Ltd?

Investing in Beryl Drugs Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Beryl Drugs Ltd or 524606 on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Beryl Drugs Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Beryl Drugs Ltd with just a few clicks!

Beryl Drugs Ltd Stock's Interest Amongst Investors

88%

Period Jun 15, 2025 to May 16, 2025. Change in 30 Days vs previous period

Search interest for Beryl Drugs Ltd Stock has increased by 88% in the last 30 days, reflecting an upward trend in search activity.

Beryl Drugs Ltd Financial Results

Get the annual and quarterly financial summary of Beryl Drugs Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue

(in ₹ Cr)

3 (0%)6 (110%)6 (10%)5 (5%)4 (25%)
Net Income

(in ₹ Cr)

-0 (0%)0 (206%)0 (97%)0 (400%)0 (200%)
Net Profit Margin-11.74% (0%)5.92% (150%)0.18% (97%)0.94% (422%)3.78% (302%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

19 (0%)18 (4%)18 (2%)18 (1%)
Total Liabilities

(in ₹ Cr)

11 (0%)11 (0%)10 (10%)9 (10%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

0 (0%)0 (89%)-0 (238%)2 (628%)1 (67%)

Beryl Drugs Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Beryl Drugs Ltd.

  • Beryl Drugs Ltd Earnings Results

    Beryl Drugs Ltd’s net profit jumped 142.86% since last year same period to ₹0.15Cr in the Q4 2024-2025. On a quarterly growth basis, Beryl Drugs Ltd has generated 200% jump in its net profits since last 3-months.

    Read More about Earnings Results

Beryl Drugs Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Beryl Drugs Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
26.38%
0.00
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
73.62%
0.00
Others
0%
0.00

Beryl Drugs Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Beryl Drugs Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA10.1349.86%0.69-126
NA6.245.19%5.69NANA
NA81.5858.65%0.51140
NA1,949.0625.81%0.5158630
NA69.916.88%0.78245

Insights on Beryl Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 45.3% return, outperforming this stock by 90.2%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 26.38% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 73.62% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 131.1% return, outperforming this stock by 14.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, Beryl Drugs stock has moved down by -16.2%

About Beryl Drugs Ltd

Beryl Drugs Ltd is a leading generic pharmaceutical manufacturing company based in Indore, India, providing a range of branded and generic formulations, I.V.fluids, a range of small and large volume injectables, eye/ear drops, veterinary products and injections. Established in 1993, with operations taken over from M/s Flora and Fauna Remedies, Beryl Drugs have successfully set up a global network of pharmaceutical manufacturing research and development, contract manufacturing services, and veterinary products. The company is in compliance with WHO GMP specifications, and has also achieved ISO 9001:2000 certification for their quality management. Beryl Drugs are popular for many of their branded products like BERICEF injection, FNeuron Amplicillin INJ, PMol Biprox, BFlox and many more.

Revenue: ₹3.97Cr as on March 2025 (Q4 FY25)
Net Profit: ₹0.15Cr as on March 2025 (Q4 FY25)
Chairperson Name: Sudhir Sethi
OrganisationBeryl Drugs Ltd
IndustryPharmaceuticals
CEOSudhir Sethi
E-voting on sharesClick here to vote

FAQs

What is Beryl Drugs Ltd share price today?

Beryl Drugs Ltd share price today stands at ₹20.09, Open: ₹18.2, Previous Close: ₹19.14, High: ₹20.09, Low: ₹18.2, 52 Week High: ₹46, 52 Week Low: ₹17.35.

What is today's traded volume of Beryl Drugs Ltd?

Today's traded volume of Beryl Drugs Ltd is 19.30K. Which means that 19.30K shares of Beryl Drugs Ltd were bought and sold on the stock market during today's trading session.

What is Beryl Drugs Ltd's market cap today?

Today's market capitalisation of Beryl Drugs Ltd is ₹10.13 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Beryl Drugs Ltd?

Beryl Drugs Ltd’s 52 week high is ₹46 and 52 week low is ₹17.35. The current share price of Beryl Drugs Ltd is ₹20.09, which is -56.33% down from its 52 week high and 15.79% up from its 52 week low.